Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-09-11
2007-09-11
Habte, Kahsay (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S118000, C544S236000, C514S233200
Reexamination Certificate
active
10738956
ABSTRACT:
The present invention provides a compound of formula (I):or a pharmaceutically acceptable salt thereof. These compounds are inhibitors of protein kinases, particularly inhibitors of PIM-1, CDK-2, GSK-3, and SRC mammalian protein kinases. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of utilizing those compounds and compositions in the treatment of various protein kinase mediated disorders.
REFERENCES:
patent: 3948912 (1976-04-01), Berger et al.
patent: 6255305 (2001-07-01), Broughton et al.
patent: 2 215 999 (1973-10-01), None
patent: 2 254 783 (1974-05-01), None
patent: 2254783 (1974-05-01), None
patent: 2 261 693 (1974-06-01), None
patent: 2 261 735 (1974-06-01), None
patent: 100 38 019 (2002-02-01), None
patent: WO99/67245 (1999-12-01), None
patent: WO 02/083139 (2002-10-01), None
patent: WO 02/083675 (2002-10-01), None
patent: WO 03/074525 (2003-09-01), None
Francavilla et al. Journal of Heterocyclic Chemistry (1971), 8(3), 415-419.
Pollack et al. Tetrahedron 1966, vol. 22, pp. 2073-2079.
Legraverend et al. Journal of Heterocyclic Chemistry (1981), 18(5), 893-898.
STN search printout (4 pages).
Bratu{hacek over (s)}k et al., “Synthesis and Reactivity of (Z)-3-benzoylamino-4-dimethylamino-2-oxo-3-butene. Preparation of 1-aryl- and 1-heteroaryl-substituted 4-benzoylamino-5-methyl-1H-pyrazoles”, Heterocycles, vol. 57, No. 11, pp. 2045-2064, (2002).
Bratu{hacek over (s)}k et al., “Transformation of 4-(1-Dimethylaminoethylidene)-2-phenyl-5(4H)-oxazolone into Methyl 2-Benzoylamino-3-oxobutanoate. The Synthesis of 1-Substituted 4-Benzoylamino-3-methyl-5(2H)-pyrazolones”, J. Het. Chem., vol. 35, pp. 1281-1284, (1998).
Parravicini, et al., “Derivati Della 3-idrazinopiridazina”, Nota II Farmaco, vol. 34., No. 4, pp. 299-310, (1979).
Vrani{hacek over (c)}ar et al., “2H-Pyran-2-ones as Synthons for (E)-α,β-Didehydroamino Acid Derivatives”, Tetrahedron, vol. 55, pp. 271-278, (1999).
Pollak et al., “Synthesis of Pyridazine Derivatives-V1Formation of s-Triazolo-(4,3-b)-pyridazines and BIS-s-Triazolo-(4,3-b,3′,4′-f)-pyridazines”, Tetrahedron, vol. 22, pp. 2073-2079, (1966).
Langof et al., “Pyridazines. LXXV. Some Quaternary and Mesoionic s-Triazolo(4,3-b)pyridazines”, Croatica Chemica Acta, vol. 47, No. 2, pp. 153-157, (1975).
Pollak et al., “Synthesis of Pyridazine Derivatives XXII. s-Triazolo[4,3-b]pyridazine 5-Oxides”, J. Het. Chem., vol. 5, No. 4, pp. 513-516, (1968).
Bregar et al., “Pyridazines, LXXXVI Some Mesoionic Mercaptoazolopyridazines”, Z. Naturforsch., vol. 31, pp. 1387-1390, (1976).
Green Jeremy
Grey, Jr. Ronald
Pierce Albert C.
Habte Kahsay
Pearson Daniel A.
Vertex Pharmaceuticals Incorporated
LandOfFree
Compositions useful as inhibitors of protein kinases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions useful as inhibitors of protein kinases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions useful as inhibitors of protein kinases will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3798182